We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.31B
AUM Growth
+$371M
Cap. Flow
+$334M
Cap. Flow %
25.5%
Top 10 Hldgs %
35.46%
Holding
2,451
New
969
Increased
258
Reduced
221
Closed
981

Sector Composition

Rank Sector Weight
1 Financials 19.52%
2 Technology 14.94%
3 Consumer Discretionary 10.12%
4 Communication Services 9.61%
5 Healthcare 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUNL
1376
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$8K ﹤0.01%
+1,430
New +$10.8K
MTEM
1377
DELISTED
Molecular Templates, Inc.
MTEM
$8K ﹤0.01%
+1,149
New +$7.85K
AEMD icon
1378
Aethlon Medical
AEMD
$1.67M
$7K ﹤0.01%
+5
New +$7.32K
CPHI icon
1379
China Pharma Holdings
CPHI
$45.8M
$7K ﹤0.01%
+426
New +$7.49K
INUV icon
1380
Inuvo
INUV
$17M
$7K ﹤0.01%
3,375
+1,967
+140% +$5.67K
XPL icon
1381
Solitario Resources
XPL
$74.8M
$7K ﹤0.01%
+11,633
New +$7.04K
YYAI icon
1382
AiRWA Inc
YYAI
$85.9K
0
TBLT
1383
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$7K ﹤0.01%
338
-516
-60% -$28.6K
INFI
1384
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$7K ﹤0.01%
34,545
-141,984
-80% -$24.7K
SRGA
1385
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$7K ﹤0.01%
40,655
+26,481
+187% +$25.4K
ADIL
1386
Adial Pharmaceuticals
ADIL
$9.43M
$6K ﹤0.01%
42
-32
-43% -$5.79K
ITP icon
1387
IT Tech Packaging
ITP
$3.26M
$6K ﹤0.01%
13,185
+1,832
+16% +$840
PRPO icon
1388
Precipio
PRPO
$39.9M
$6K ﹤0.01%
811
+92
+13% +$1.04K
LNAI
1389
Lunai Bioworks
LNAI
$10.9M
$6K ﹤0.01%
+138
New +$10.6K
TCBP
1390
DELISTED
TC BioPharm (Holdings) plc American Depositary Shares
TCBP
$6K ﹤0.01%
+4
New +$12.8K
AKU
1391
DELISTED
Akumin Inc
AKU
$6K ﹤0.01%
+33,156
New +$15.2K
MBSC.WS
1392
DELISTED
M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
MBSC.WS
$6K ﹤0.01%
12,992
+526
+4% +$219
TKAT
1393
DELISTED
Takung Art Co., Ltd.
TKAT
$6K ﹤0.01%
16,089
-25,937
-62% -$13.4K
GMVD
1394
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
$6K ﹤0.01%
+14,602
New +$6.58K
AMPE
1395
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$6K ﹤0.01%
1,265
+516
+69% +$2.53K
AMBO
1396
Ambow Education Holding
AMBO
$5.61M
$5K ﹤0.01%
+2,155
New +$5.34K
CTRM icon
1397
Castor Maritime
CTRM
$19.9M
$5K ﹤0.01%
1,108
-4,090
-79% -$24.6K
HUBCZ icon
1398
Hub Cyber Security Warrant
HUBCZ
$70.8K
$5K ﹤0.01%
+12,566
New +$3.41K
LGHL
1399
Lion Group Holding
LGHL
$725K
0
RVSN icon
1400
Rail Vision
RVSN
$10.2M
$5K ﹤0.01%
42
-11
-21% -$2.07K

Similar funds

Virtu Financial's Q2 2023 Portfolio in Review

As of Q2 2023, Virtu Financial held 2,451 positions worth $1.31B, up 40% from $940M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Virtu Financial deployed $334M of net new capital in Q2 2023, opening 969 new positions and adding to 258 existing holdings. Its largest new stake was Tesla: 131,896 shares worth $34.5M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Real Estate ETF, an estimated $16.7M trimmed.

  • Virtu Financial's largest Q2 2023 buy was Tesla: 131,896 shares worth $34.5M.
  • Virtu Financial added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $103M increase.
  • Virtu Financial's biggest Q2 2023 reduction was Vanguard Real Estate ETF, cutting an estimated $16.7M.
  • Virtu Financial fully exited Yamana Gold, Inc. in Q2 2023, selling an estimated $52.4M.
  • Virtu Financial's ten largest holdings make up 35% of its $1.31B portfolio in Q2 2023.
  • Virtu Financial opened 969 new positions and closed 981 in Q2 2023.
  • Virtu Financial's portfolio value rose 40% quarter-over-quarter to $1.31B.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.